Navigation Links
ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
Date:4/10/2008

egarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward looking statements as a result of a number of important factors, including the results of clinical trials, the timing of regulatory approvals, the integration of 3f Therapeutics and the surgical cryoablation business of CryoCath Technologies, Inc., regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2007.


'/>"/>
SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
2. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
3. Honeywell HomMed Wins 2008 Medical Design Excellence Award for Genesis DM Remote Care Device
4. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
5. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
6. Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus
7. ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million
8. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
9. Tryton Medical, Inc. Closes $14 Million Financing
10. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
11. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)...  Turing Pharmaceuticals AG announced that life sciences executive ... MSc,  has joined the company as president of ... holds a medical degree as well as a ... accomplishments in the pharmaceutical industry, and extensive clinical ... played a leadership role in numerous programs for ...
(Date:6/1/2015)... and YONGIN, South Korea , June ... that Green Cross Biotherapeutics Inc. (GCBT) kicked off construction ... on the Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million ... projects in Canada in the ... first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... 1, 2015 GenomeDx Biosciences today ... platform, successfully classified various subtypes of bladder ... certain biomarkers, including one type associated with ... genomic signature has potential as a tool ... in patients with muscle-invasive bladder cancers (MIBC). ...
(Date:6/1/2015)... GUELPH, ON , June 1, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: ... month period ended March 31, 2015.  Biorem,s complete 2015 first quarter ... ). Financial Summary:Three-months ended March 31,(in CDN$,000 ... Revenue , 4,689 , 1,974 Gross profit , ... , (318) Net earnings (loss) , 528 , ...
Breaking Biology Technology:Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3
... Marketing and Sales; Susan Koppy ... President, Corporate Development, PT. RICHMOND, Calif., July 2 ... the position of,Vice President, Marketing and Sales and Susan Koppy ... and Ms. Koppy will report,to President & Chief Executive Officer ...
... Aureus Pharma, a leading provider of,knowledge management ... announced today that the Aureus Pharma 2008 User ... and 24th., This symposium follows last year,s ... of Aureus, pharmaceutical and biotech customers,from both Europe ...
... R2 levels as a possible ... predictor of clinical activity -, ... LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company,specializing in the ... of cancer, today announced publication by,an Ohio State University (OSU) ...
Cached Biology Technology:Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4Aureus Pharma Announces Date of 2008 Annual User Symposium 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/7/2015)... , May 7, 2015 ... fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest touch ... FPC1035 are mainly considered for integration on the ... gives smartphone OEMs increased possibilities to integrate touch ... decreased size also improves possibilities for module manufacturers ...
(Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... work involving 2,700 researchers from 80 countries, the world,s scientists ... Census of Marine Life, which provides the first in-depth look ... The Census of Marine Life initiative, started in 2000, is ... , the result of more than 540 expeditions and 9,000 days ...
... oil long encouraged by doctors as a supplement to ... severe colitis and colon cancer in mice in research led ... journal Cancer Research . Jenifer Fenton, a food ... that supports establishing a dose limit for docosahexaenoic acid (DHA), ...
... congratulates Cambridge scientist and Editor Emeritus of Reproductive ... been awarded with the 2010 Nobel Prize in Medicine ... that has helped millions of infertile couples worldwide to ... a procedure in which egg cells are fertilised outside ...
Cached Biology News:San Diego Supercomputer Center participates in first 'Census of Marine Life' 2Fish oil linked to increased risk of colon cancer in mice 2Nobel Prize for Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online 2
... Expand the computing power of your ... TTL on-off sequences with a Macintosh computer ... unlimited programs to disk, print out program ... ValveBank's memory in one simple step., EasyCode ...
... The Jouan MSC series of ... comfortable working conditions and certification to ... automatic regulation ensures that the cabinets ... working conditions. Natural lighting, low noise ...
... The Holten MaxiSafe 2010 Class II ... ergonomical working condition of comfort while ... efficiency and performance.,Refined operator, environment and ... both exhausted and recirculated air.,Bottom filters ...
... The Magnetic Stand-96 is designed for ... microplates and 0.2 ml PCR plates with ... clear polyacryl base in a standard SBS ... extremely strong permanent magnets guarantees easy and ...
Biology Products: